The Cinch Annuloplasty Device is developed to provide a percutaneous, quick, safe and simple solution to a complex problem. It allows the tricuspid valve to function as it is intended and leaves a mimimal anatomic footprint. The Cinch Annuloplasty Device is designed and tested by experienced structural heart interventionalists and developed with the world-leading engineering team at Resolution Medical. IP is maintained through HOFFMANN EITLE. The tech has been developed through 3 years of testing and iterations based on test data and KOL user input including bench at Resolution Medical, beating heart model at LifeTec Group™ successful 10 minute In-vivo deployment in an animal modal at the pre-clinical reference lab at Veranex Preclinical Services, France (Formerly known as IMMR) in Paris with extremely encouraging results. The project has been supported by Haukeland universitetssjukehus, VIS - Vestlandets Innovasjonsselskap, Norges forskningsråd, GRIEG FOUNDATION and GC Rieber AS. Following our successful first-in-animal trial we are now aiming to expand our clinical and financial partnerships towards first-in-man device implantation.
Om oss
Cinch Medical is developing catether-based solutions to functional tricuspid regurgitation. Currently, no simple, quick and safe solution exists for this huge patient population - Cinch Medical intends to change this.
- Nettsted
-
CinchMedTech.com
Ekstern lenke til Cinch Medical AS
- Bransje
- Bioteknologisk forskning
- Bedriftsstørrelse
- 2–10 ansatte
- Hovedkontor
- Bergen
- Type
- Åpent aksjeselskap
- Grunnlagt
- 2023
- Spesialiteter
- Structural Heart Intervention, MedTech
Beliggenheter
-
Primær
Få veibeskrivelse
Bergen, NO
Ansatte i Cinch Medical AS
Oppdateringer
-
Great week in Minneapolis with fantastic people! R&D from Resolution Medical and BioSimulation from LifeTec Group™ . Big thanks to NORWAYHOUSE BARN , the Honorary Consul of Norway Eivind Heiberg and StartUSA Inc.! Looking forward to next week in Paris at #EuroPCR #PCRInnovatorsDay with PCR #PCRPresenter
-
-
Looking forward to #EuroPCR 2024! We are presenting the Cinch #Tricuspid #annuloplasty solution at PCR Innovators day May 13th! Excited to meet up and discuss recent progress with friends, colleagues as well as potential new partners! #TreatTR
-
Cinch goes to #PCRLV! Excited to meet and discuss all things #tricuspid #annuloplasty with great colleagues, friends and fantastic faculty! #TreatTR Hope to see you there!